ReviewFrontiers in nutrition2025

Pre-treatment endocrine-nutritional signatures predict clinical benefit from PD-1/PD-L1 blockade in hematologic malignancies.

Ningjing Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.